Asian Science Citation Index is committed to provide an authoritative, trusted and significant information by the coverage of the most important and influential journals to meet the needs of the global scientific community.  
ASCI Database
308-Lasani Town,
Sargodha Road,
Faisalabad, Pakistan
Fax: +92-41-8815544
Contact Via Web
Suggest a Journal
Journal of Biopharmaceutical Statistics
Year: 2010  |  Volume: 20  |  Issue: 6  |  Page No.: 1143 - 1149

FDA Draft Guidance on Adaptive Design Clinical Trials: Pfizer’s Perspective

Christy Chuang-Stein and Mohan Beltangady    

Abstract: The Food and Drug Administration of the United States issued a draft guidance on adaptive design clinical trials in February 2010. This draft guidance has attracted a lot of attention because of the increasing interest in adaptive trials by the pharmaceutical industry in recent years. In this paper, we report on highlights of comments collected within Pfizer on this draft guidance. In addition, we share Pfizer’s internal journey to promote efficient trial designs since 2005. Adaptive designs have been part of that journey.

View Fulltext    |   Related Articles   |   Back
  Related Articles

No Article Found
Copyright   |   Desclaimer   |    Privacy Policy   |   Browsers   |   Accessibility